Will taking Azithromycin (Azithromycin) and Cefixime (Cefixime) 2 days prior to the Widal test alter the results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Impact of Azithromycin and Cefixime on Widal Test Results

Yes, taking azithromycin and cefixime 2 days prior to the Widal test will likely alter the test results, potentially leading to false negative results due to the antibiotics' effect on bacterial growth and antibody production. 1

Understanding the Widal Test and Its Limitations

  • The Widal test is a serological test that detects antibodies against Salmonella typhi and paratyphi antigens in a patient's serum 1
  • The test already has inherent limitations in sensitivity and specificity, making interpretation challenging even without antibiotic interference 1
  • Guidelines specifically note that "the serological Widal test lacks sensitivity and specificity and is not recommended" as a standalone diagnostic tool for typhoid fever 1

How Antibiotics Affect Widal Test Results

  • Antibiotics like azithromycin and cefixime can suppress bacterial growth, reducing antigenic stimulation and thereby decreasing antibody production 1
  • This suppression can lead to lower antibody titers than would otherwise be present, potentially resulting in false negative results 1
  • Even short-term antibiotic use (2 days in this case) can begin to impact the immune response and subsequent antibody levels 1

Preferred Diagnostic Methods for Typhoid Fever

  • Blood cultures have the highest diagnostic yield within the first week of symptom onset and are considered the gold standard for diagnosis 1
  • The sensitivity for blood cultures is reported as 40-80% (potentially higher with modern methods) 1
  • Bone marrow cultures have even higher sensitivity than blood cultures, though they are more invasive 1, 2
  • Stool and urine cultures become positive after the first week of illness 1

Recommendations for Accurate Diagnosis

  • If typhoid fever is suspected, blood samples for culture should ideally be collected before starting antimicrobial therapy 1, 2
  • If the Widal test must be performed after antibiotics have been started, results should be interpreted with extreme caution 3, 4
  • Consider newer rapid serological tests detecting IgM against specific antigens (e.g., Typhidot, Tubex) which may be less affected by prior antibiotic use, though these also show mixed results 1

Treatment Considerations

  • If there is strong clinical suspicion of typhoid fever and the patient's condition is unstable, empiric treatment should be initiated pending blood culture results 1
  • For treatment of typhoid fever, azithromycin is considered an effective oral option, particularly for fluoroquinolone-resistant isolates 1
  • Cefixime has shown treatment failure rates of 4-37.6% when used as an oral first-line agent for typhoid fever 1
  • To reduce risk of relapse, treatment should be continued for 14 days 1

Key Pitfalls to Avoid

  • Relying solely on Widal test results for diagnosis, especially after antibiotic administration 1, 4
  • Failing to obtain blood cultures before initiating antibiotics 1, 2
  • Misinterpreting low Widal titers in a patient who has already received antibiotics as ruling out typhoid fever 3, 4
  • Using inappropriate cutoff values for Widal test interpretation (cutoffs vary by region and endemic status) 3, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Typhoid Fever in Infants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Widal test in diagnosis of typhoid fever in Turkey.

Clinical and diagnostic laboratory immunology, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.